Results per Page:
Polygenic risk scores and prostate cancer
New research shows genetic risk scores could help distinguish who can cut back on ‘active surveillance’
Active surveillance shown to be an effective management strategy for prostate cancer patients
Study evaluated long-term outcomes of using active surveillance instead of immediate treatment with surgery or radiation
Good and surprising news finds germline mutations are rare in low-risk prostate cancer
From the Nelson Lab, part of the Human Biology and Public Health Sciences Divisions
Dr. Yingye Zheng named fellow of American Statistical Association
Honored for work to develop biomedical decision tools
African Americans and the risk of reclassification in Active Surveillance
From the Lin Group, Division of Public Health Sciences
Black men with early-stage prostate cancer can do active surveillance
New study using Canary PASS data shows African American men with low-risk disease can delay radical treatment just like white men
Fred Hutch receives 5 years of NCI funding to grow and maintain key prostate cancer cohort
$6.7M grant will boost size, participant diversity of Canary Prostate Active Surveillance Study
6 things men need to know about prostate cancer
Experts share their insight on screening, treatment, clinical trials and more